Teva settles Nuvigil litigation with Mylan
30 April 2012
TEVA, has settled patent infringement litigation with Mylan Inc.'s ANDA for Teva’s wakefulness product NUVIGIL® (armodafinil) tablets...
Industry news
Algeta and Sanofi extend research collaboration evaluating thorium-conjugated tumor-targeting antibody
30 April 2012
Algeta ASA announces that its research collaboration with Sanofi has been extended...
Switching to TWYNSTA® allows patients with uncontrolled hypertension on monotherapy to rapidly reach their blood pressure goals
29 April 2012
New data on TWYNSTA®...
Japan chooses Sanofi Pasteur for first enhanced Inactivated Polio Vaccine
27 April 2012
Approval of IMOVAX® POLIO by Japanese health authorities...
AstraZeneca needs new strategy after boardroom shake up – EP Vantage investigates
27 April 2012
As AstraZeneca PLC Chief Executive David Brennan steps down...
Merck wins U.S. ZETIA® (ezetimibe) / VYTORIN® (ezetimibe/simvastatin) patent infringement lawsuit
27 April 2012
"The court appropriately ruled that the patent for ZETIA and VYTORIN in the U.S. is valid..."
Novo Nordisk A/S expects to elect new chairman in 2013
27 April 2012
Sten Scheibye has been elected to the Board of the Novo Nordisk Foundation...
GlaxoSmithKline receives European authorisation for Nimenrix™
27 April 2012
The European Commission has granted marketing authorisation for Nimenrix...
Novartis drug Afinitor® approved by FDA as first medication to treat patients with non-cancerous kidney tumors associated with TSC
26 April 2012
The FDA has approved Afinitor® tablets...
FDA approves Votrient® for treatment of patients with certain types of advanced soft tissue sarcoma
26 April 2012
GlaxoSmithKline plc announced that the U.S. FDA has approved Votrient® (pazopanib)...
More than 25,000 Novartis associates worldwide to volunteer for local causes in Community Partnership Day
26 April 2012
Novartis associates to dedicate 200,000 work hours to supporting the local community...
In-depth focus:
Mass Spectrometry
This free to view Mass Spectrometry in-depth focus is sponsored by Waters, Bruker, Protea and Dr. Hochmuth and contains the following articles:
- Mass spectrometry in drug discovery - Proteomics, small molecules and metablomics
- Quantification of membrane drug transporters and application in drug discovery and development
- Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
Company directory
ABB Analytical Measurements | Almac | B&W Tek, Inc. | BASF | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Optics | CAMO Software AS | Catalent Pharma Solutions | Chemspec Europe Ltd | CI Precision | Cisbio Bioassays | EMD Millipore | GE Analytical Instruments | Gerresheimer Group | HACH LANGE GMBH | HORIBA Scientific | I Holland Limited | Lonza | Merck Millipore | Pall Life Sciences | Patheon Inc | Phenomenex | Porvair Sciences Ltd | Randox Pharma Services | Rapid Micro Biosystems | Realia | Roche | rommelag® | Umetrics |
Login to access exclusive content